Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency.

The observation that high-dose oral vitamin E supplementation (800 IU per day) improved red-cell survival in two rare disorders associated with increased red-cell susceptibility to oxidative stress prompted a similar trial in 23 patients with Mediterranean glucose-6-phosphate dehydrogenase (G6PD) deficiency. Three months of vitamin E administration resulted in decreased chronic hemolysis as evidenced by improved red-cell life span (P less than 0.025), with an improvement in red-cell half-life from 22.9 +/- 0.7 days to 25.1 +/- 0.6 days (mean +/- S.E.M.), increased hemoglobin concentration (P less than 0.001), and decreased reticulocytosis (P less than 0.001) as compared with base-line values. Evaluation after one year of vitamin E administration demonstrated sustained improvement in all these indexes. Controlled clinical trials of vitamin E supplementation may be warranted to examine its efficacy in ameliorating acute hemolytic crises or in reducing morbidity from neonatal jaundice in this relatively common genetic disorder.

[1]  C. Rizzi.  Statistical Methods , 2020, Springer Theses.

[2]  V. Herbert.  The nutritional anemias. , 1980, Hospital practice.

[3]  J. Schulman,et al.  Improved erythrocyte survival with high-dose vitamin E in chronic hemolyzing G6PD and glutathione synthetase deficiencies. , 1979, Annals of internal medicine.

[4]  N. Matsaniotis,et al.  Relationship between tocopherols and serum lipid levels in children with beta-thalassemia major. , 1978, The American journal of clinical nutrition.

[5]  L. Luzzatto,et al.  Human erythrocyte glucose 6-phosphate dehydrogenase: structure and function in normal and mutant subjects. , 1978, Current topics in hematology.

[6]  W. Engel,et al.  Erythrocyte survival in Duchenne muscular dystrophy , 1977, Neurology.

[7]  D. Cornwell,et al.  Role of vitamin E in glutathione-induced oxidant stress: methemoglobin, lipid peroxidation, and hemolysis. , 1977, Journal of lipid research.

[8]  P. di Sant'Agnese,et al.  The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis. , 1977, The Journal of clinical investigation.

[9]  J. G. Bieri,et al.  Factors affecting the exchange of tocopherol between red blood cells and plasma. , 1977, The American journal of clinical nutrition.

[10]  S. Bannai,et al.  Effect of antioxidants on cultured human diploid fibroblasts exposed to cystine-free medium. , 1977, Biochemical and biophysical research communications.

[11]  E. Beutler,et al.  The removal of leukocytes and platelets from whole blood. , 1976, The Journal of laboratory and clinical medicine.

[12]  P. Farrell,et al.  Megavitamin E supplementation in man. , 1975, The American journal of clinical nutrition.

[13]  W. McWhirter.  PLASMA TOCOPHEROL IN INFANTS AND CHILDREN , 1975, Acta paediatrica Scandinavica.

[14]  Ernest Beutler,et al.  Red Cell Metabolism: A Manual of Biochemical Methods , 1975 .

[15]  J. Cook,et al.  Measurement of serum ferritin by a 2-site immunoradiometric assay. , 1974, Analytical biochemistry.

[16]  M. Horwitt,et al.  RELATIONSHIP BETWEEN TOCOPHEROL AND SERUM LIPID LEVELS FOR DETERMINATION OF NUTRITIONAL ADEQUACY * , 1972, Annals of the New York Academy of Sciences.

[17]  G. Stamatoyannopoulos,et al.  Genetic diversity of the "Mediterranean" glucose-6-phosphate dehydrogenase deficiency phenotype. , 1971, The Journal of clinical investigation.

[18]  M. Losowsky,et al.  Effect of alpha-tocopherol administration on red cell survival in vitamin E-deficient human subjects. , 1971, The American journal of clinical nutrition.

[19]  S. Piomelli,et al.  The Haematological Effects of Glucose‐6‐Phosphate Dehydrogenase Deficiency and Thalassaemia Trait: Interaction between the Two Genes at the Phenotype Level , 1969, British journal of haematology.

[20]  P. H. Tarukoski.  Quantitative spectrophotometric determination of haptoglobin. , 1966, Scandinavian journal of clinical and laboratory investigation.

[21]  L. Wasserman,et al.  MEASUREMENT OF SERUM VITAMIN B12 LEVEL USING RADIOISOTOPE DILUTION AND COATED CHARCOAL. , 1965, Blood.

[22]  H. Kirkman,et al.  DIVERSE CHARACTERISTICS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE FROM GREEK CHILDREN. , 1965, The Journal of laboratory and clinical medicine.

[23]  M. Adinolfi,et al.  Survival of 51Cr‐Labelled Red Cells in Subjects with Thalassaemia‐Trait or G6PD Deficiency or Both Abnormalities , 1964, British journal of haematology.

[24]  E. Beutler,et al.  Improved method for the determination of blood glutathione. , 1963, The Journal of laboratory and clinical medicine.

[25]  L. Garby,et al.  The amount of trapped plasma in a high speed micro-capillary hematocrit centrifuge. , 1961, Scandinavian journal of clinical and laboratory investigation.

[26]  G. Brecher,et al.  Evaluation of electronic red blood cell counter. , 1956, American journal of clinical pathology.

[27]  P. Gyorgy,et al.  Hemolysis with alloxan and alloxan-like compounds, and the protective action of tocopherol. , 1950, Blood.

[28]  O. H. Lowry,et al.  A micromethod for assay of total tocopherols in blood serum. , 1949, The Journal of biological chemistry.

[29]  G. Brecher.  New methylene blue as a reticulocyte stain. , 1949, American journal of clinical pathology.